TY  - CHAP
M1  - Book, Section
TI  - Osteoarthritis
A1  - Piszczatoski, Christopher R.
A1  - Smith, Steven M.
A1  - Gums, John
A2  - Chisholm-Burns, Marie A.
A2  - Schwinghammer, Terry L.
A2  - Malone, Patrick M.
A2  - Kolesar, Jill M.
A2  - Bookstaver, P. Brandon
A2  - Lee, Kelly C.
Y1  - 2022
N1  - 
T2  - Pharmacotherapy Principles & Practice, 6e
AB  - LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Explain  the  pathophysiologic  mechanisms  involved  in  the  development  of  osteoarthritis  (OA).Identify  risk  factors  associated  with  OA.Recognize  the  clinical  presentation  of  OA.Determine  the  goals  of  therapy  for  individual  patients  with  OA.Formulate  a  rational  nonpharmacologic  plan  for  patients  with  OA.Recommend  a  pharmacologic  plan  for  treating  OA,  taking  into  consideration  patient-specific  factors.Develop  monitoring  parameters  to  assess  effectiveness  and  adverse  effects  of  pharmacotherapy  for  OA.Modify  an  unsuccessful  treatment  strategy  for  OA.Deliver  effective  patient  counseling,  including  lifestyle  modifications  and  drug  therapy,  to  facilitate  effective  and  safe  management  of  OA.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/10/07
UR  - ppp.mhmedical.com/content.aspx?aid=1187024709
ER  -